From: Clinical features and outcomes of neck lymphatic metastasis in ovarian epithelial carcinoma
Patient | Age at | Histology | Tumor location | Interval between | Interval between | Recurrence/ | Survival | Dead from disease |
---|---|---|---|---|---|---|---|---|
no. | NLNM | Â | at initial | NLNM and cancer | primary surgery | metastasis | after NLNM | at the end of |
 | (years) |  | operation | recurrence (months) | and NLNM (months) | sites | (months) | follow-up |
Group A | ||||||||
1 | 55 | Serous | Ovaries | - | Â | - | 115 | No |
2 | 61 | Serous | Ovary | 51 | Â | LN | 82 | No |
3 | 48 | Serous | Ovary | 9 | Â | LN | 42 | No |
4 | 50 | Serous | Ovaries and tubes | 18 | Â | LN | 93 | No |
5 | 73 | Serous | Ovaries and tubes | 33 | Â | LN | 44 | Yes |
6 | 43 | Serous | Ovaries and pelvic | 25 | Â | LN | 76 | No |
7 | 54 | Clear | Pelvic and abdominal cavities | Progress | Â | Bone | 21 | Yes |
8 | 61 | Squamous cell | Pelvic and abdominal cavities | Progress | Â | Â | 6 | Yes |
9 | 46 | Serous | Pelvic and abdominal cavities | 8 | Â | Peritoneal cavity | 16 | Yes |
10 | 55 | Serous | Pelvic and abdominal cavities | 15 | Â | Brain | 18 | Yes |
11 | 80 | Serous | Pelvic and abdominal cavities, pleural effusion | 10 | Â | Peritoneal cavity, lung | 28 | Yes |
Group B | ||||||||
12 | 66 | Serous | Pelvic and abdominal cavities | Â | 12 | LN | 22 | No |
13 | 42 | Serous | Pelvic and abdominal cavities | Â | 13 | LN | 41 | Yes |
14 | 38 | Endometrioid | Pelvic cavity | Â | 117 | LN, peritoneal cavity | 6 | Yes |
15 | 69 | Serous | Pelvic cavity | Â | 110 | LN, peritoneal cavity, brain | 3 | Yes |
16 | 44 | Serous | Pelvic and abdominal cavities | Â | 62 | LN, peritoneal cavity, brain | 3 | Yes |
17 | 59 | Clear | Pelvic and abdominal cavities | Â | 5 | LN, peritoneal cavity, bone | 4 | Yes |
18 | 48 | Clear | Pelvic cavity | Â | 20 | LN, peritoneal cavity, bone, brain | 7 | Yes |
19 | 62 | Serous | Pelvic and abdominal cavities | Â | 13 | LN, lung | 35 | Yes |
20 | 43 | Clear | Pelvic cavity | Â | 38 | LN, brain | 1 | Yes |